AAAAAA
Results:
1-23
|
Results: 23
Authors:
BAEYENS V
KALTSATOS V
BOISRAME B
VARESIO E
VEUTHEY JL
FATHI M
BALANT LP
GEXFABRY M
GURNY R
Citation: V. Baeyens et al., OPTIMIZED RELEASE OF DEXAMETHASONE AND GENTAMICIN FROM A SOLUBLE OCULAR INSERT FOR THE TREATMENT OF EXTERNAL OPHTHALMIC INFECTIONS, Journal of controlled release, 52(1-2), 1998, pp. 215-220
Authors:
GEXFABRY M
BALANTGORGIA AE
BALANT LP
Citation: M. Gexfabry et al., THERAPEUTIC DRUG-MONITORING DATABASES FOR POSTMARKETING SURVEILLANCE OF DRUG-DRUG INTERACTIONS - EVALUATION OF A PAIRED APPROACH FOR PSYCHOTROPIC MEDICATION, Therapeutic drug monitoring, 19(1), 1997, pp. 1-10
Authors:
MARZO A
BALANT LP
Citation: A. Marzo et Lp. Balant, INVESTIGATION OF XENOBIOTIC METABOLISM BY CYP2D6 AND CYP2C19 - IMPORTANCE OF ENANTIOSELECTIVE ANALYTICAL METHODS, Journal of chromatography B. Biomedical applications, 678(1), 1996, pp. 73-92
Authors:
VOZEH S
STEIMER JL
ROWLAND M
MORSELLI P
MENTRE F
BALANT LP
AARONS L
Citation: S. Vozeh et al., THE USE OF POPULATION PHARMACOKINETICS IN DRUG DEVELOPMENT, Clinical pharmacokinetics, 30(2), 1996, pp. 81-93
Authors:
BALANTGORGIA AE
RIES C
BALANT LP
Citation: Ae. Balantgorgia et al., METABOLIC INTERACTION BETWEEN FLUOXETINE AND CLOMIPRAMINE - A CASE-REPORT, Pharmacopsychiatry, 29(1), 1996, pp. 38-41
Authors:
PARSIAN A
TODD RD
CLONINGER CR
HOFFMAN PL
OVCHINNIKOVA L
IKEDA H
TABAKOFF B
SCHUCKIT MA
RAPPAPORT M
TSUANG J
SALASPURO M
MONTEIRO MG
BALANT LP
DAVIDSON C
OGATA M
YAMASHITA I
GRANT BF
Citation: A. Parsian et al., PLATELET ADENYLYL-CYCLASE ACTIVITY IN ALCOHOLICS AND SUBTYPES OF ALCOHOLICS, Alcoholism, clinical and experimental research, 20(4), 1996, pp. 745-751
Authors:
BALANT LP
GEXFABRY M
BALANTGORGIA E
Citation: Lp. Balant et al., DRUG-METABOLISM AS A CONFOUNDING FACTOR IN PK PD POPULATION APPROACHES/, Therapie, 51(4), 1996, pp. 390-398
Authors:
BALANTGORGIA AE
GEXFABRY M
BALANT LP
Citation: Ae. Balantgorgia et al., THERAPEUTIC DRUG-MONITORING AND DRUG-DRUG INTERACTIONS - A PHARMACOEPIDEMIOLOGIC PERSPECTIVE, Therapie, 51(4), 1996, pp. 399-402
Authors:
AARONS L
BALANT LP
MENTRE F
ROWLAND M
STEIMER JL
VOZEH S
Citation: L. Aarons et al., PRACTICAL EXPERIENCE AND ISSUES IN DESIGNING AND PERFORMING POPULATION PHARMACOKINETIC PHARMACODYNAMIC STUDIES/, European Journal of Clinical Pharmacology, 49(4), 1996, pp. 251-254
Authors:
GRAVEL P
WALZER C
AUBRY C
BALANT LP
YERSIN B
HOCHSTRASSER DF
GUIMON J
Citation: P. Gravel et al., NEW ALTERATIONS OF SERUM GLYCOPROTEINS IN ALCOHOLIC AND CIRRHOTIC-PATIENTS REVEALED BY HIGH-RESOLUTION 2-DIMENSIONAL GEL-ELECTROPHORESIS, Biochemical and biophysical research communications, 220(1), 1996, pp. 78-85
Authors:
MEYER UA
AMREIN R
BALANT LP
BERTILSSON L
EICHELBAUM M
GUENTERT TW
HENAUER S
JACKSON P
LAUX G
MIKKELSEN H
PECK C
POLLOCK BG
PRIEST R
SJOQVIST F
DELINISTULA A
Citation: Ua. Meyer et al., ANTIDEPRESSANTS AND DRUG-METABOLIZING-ENZYMES - EXPERT GROUP-REPORT, Acta psychiatrica Scandinavica, 93(2), 1996, pp. 71-79
Authors:
BALANTGORGIA EA
BALANT LP
Citation: Ea. Balantgorgia et Lp. Balant, THERAPEUTIC DRUG-MONITORING - RELEVANCE DURING THE DRUG-TREATMENT OF PSYCHIATRIC-DISORDERS, CNS DRUGS, 4(6), 1995, pp. 432-453
Authors:
BAJETTA E
COLLEONI M
DIBARTOLOMEO M
BUZZONI R
BOZZETTI F
DOCI R
SOMMA L
CAPPUZZO F
STAMPINO CG
GUENZI A
BALANT LP
ZILEMBO N
DILEO A
Citation: E. Bajetta et al., DOXIFLURIDINE AND LEUCOVORIN - AN ORAL TREATMENT COMBINATION IN ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 13(10), 1995, pp. 2613-2619
Authors:
GURTLER F
KALTSATOS V
BOISRAME B
DELEFORGE J
GEXFABRY M
BALANT LP
GURNY R
Citation: F. Gurtler et al., OCULAR AVAILABILITY OF GENTAMICIN IN SMALL ANIMALS AFTER TOPICAL ADMINISTRATION OF A CONVENTIONAL EYE DROP SOLUTION AND A NOVEL LONG-ACTINGBIOADHESIVE OPHTHALMIC DRUG INSERT, Pharmaceutical research, 12(11), 1995, pp. 1791-1795
Authors:
GRAVEL P
SANCHEZ JC
WALZER C
GOLAZ O
HOCHSTRASSER DF
BALANT LP
HUGHES GJ
GARCIASEVILLA J
GUIMON J
Citation: P. Gravel et al., HUMAN BLEED PLATELET PROTEIN MAP ESTABLISHED BY 2-DIMENSIONAL POLYACRYLAMIDE-GEL ELECTROPHORESIS, Electrophoresis, 16(7), 1995, pp. 1152-1159
Authors:
GEXFABRY M
BALANTGORGIA AE
BALANT LP
Citation: M. Gexfabry et al., POTENTIAL OF CONCENTRATION MONITORING DATA FOR A SHORT HALF-LIFE DRUG- ANALYSIS OF PHARMACOKINETIC VARIABILITY FOR MOCLOBEMIDE, Therapeutic drug monitoring, 17(1), 1995, pp. 39-46
Authors:
MARZO A
BALANT LP
Citation: A. Marzo et Lp. Balant, BIOEQUIVALENCE - AN UPDATED REAPPRAISAL ADDRESSED TO APPLICATIONS OF INTERCHANGEABLE MULTISOURCE PHARMACEUTICAL PRODUCTS, Arzneimittel-Forschung, 45-1(2), 1995, pp. 109-115
Authors:
AARONS L
BALANT LP
MENTRE F
MORSELLI PL
ROWLAND M
STEIMER JL
VOZEH S
Citation: L. Aarons et al., POPULATION APPROACHES IN DRUG DEVELOPMENT - REPORT ON AN EXPERT MEETING TO DISCUSS POPULATION PHARMACOKINETIC PHARMACODYNAMIC SOFTWARE/, European Journal of Clinical Pharmacology, 46(5), 1994, pp. 389-391
Authors:
BALANT LP
GEXFABRY M
Citation: Lp. Balant et M. Gexfabry, DEALING WITH VARIABILITY DURING DRUG DEVELOPMENT, Journal of Pharmacy and Pharmacology, 46, 1994, pp. 439-444
Authors:
GRAVEL P
GOLAZ O
WALZER C
HOCHSTRASSER DF
TURLER H
BALANT LP
Citation: P. Gravel et al., ANALYSIS OF GLYCOPROTEINS SEPARATED BY 2-DIMENSIONAL GEL-ELECTROPHORESIS USING LECTIN BLOTTING REVEALED BY CHEMILUMINESCENCE, Analytical biochemistry, 221(1), 1994, pp. 66-71
Authors:
BALANTGORGIA AE
BALANT LP
ANDREOLI A
Citation: Ae. Balantgorgia et al., PHARMACOKINETIC OPTIMIZATION OF THE TREATMENT OF PSYCHOSIS, Clinical pharmacokinetics, 25(3), 1993, pp. 217-236
Authors:
BALANT LP
ROWLAND M
AARONS L
MENTRE F
MORSELLI PL
STEIMER JL
VOZEH S
Citation: Lp. Balant et al., NEW STRATEGIES IN DRUG DEVELOPMENT AND CLINICAL-EVALUATION - THE POPULATION APPROACH - COMMENTARY ON AN ACTION FOR COOPERATIVE RESEARCH, European Journal of Clinical Pharmacology, 45(2), 1993, pp. 93-94
Authors:
BALANTGORGIA AE
GAY M
GEXFABRY M
BALANT LP
Citation: Ae. Balantgorgia et al., PERSISTENT IMPAIRMENT OF CLOMIPRAMINE DEMETHYLATION IN RECENTLY DETOXIFIED ALCOHOLIC PATIENTS, Therapeutic drug monitoring, 14(2), 1992, pp. 119-124
Risultati:
1-23
|